Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 416, pseudogene" (RNU6-416P) is a pseudogene derived from the U6 small nuclear RNA gene family[2][7][8]. U6 small nuclear RNA is a highly conserved and essential non-coding RNA component of the spliceosome, involved in the excision of introns from pre-mRNA during RNA splicing[3][1]. Pseudogenes like RNU6-416P do not produce functional RNA or protein products and are considered non-functional genomic elements, often resulting from retrotransposition or gene duplication events[5][7]. These pseudogenes are prevalent throughout the genome but do not serve as therapeutic targets, nor do they have known direct roles in disease, drug interactions, or biomarker utility. RNU6-416P has several recorded identifiers (HGNC: 47379; NCBI Gene: 106480579; Ensembl: ENSG00000252074), but it lacks recognized functional, clinical, or mechanistic significance[7][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 416, pseudogene (RNU6-416P).